CNBC's Jim Cramer on Monday told investors they may be wise to sit out Wednesday's Birkenstock IPO.
CNBC's Jim Cramer on Monday told investors not to immediately buy shares of Birkenstock when it IPOs this week.
Birkenstock is expected to attain a $10 billion valuation and is seeking to price shares at the top of its $44 to $49 range, Reuters"In the end, Birkenstock has a great product — one that even found its way into the incredibly popular 'Barbie' movie — but you need to be very careful with its stock after the IPO on Wednesday," Cramer said. "I worry that it'll be too expensive right out of the gate and will only get more expensive in the initial feeding frenzy.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Jim Cramer says investors should wait and see with Birkenstock's IPOCNBC's Jim Cramer on Monday told investors they may be wise to sit out Wednesday's Birkenstock IPO.
Lire la suite »
Birkenstock IPO expected to prove the next test of investor appetite for dealsDeal comes at a time of weak aftermarket performance by recent deals
Lire la suite »
Birkenstock eyes pricing IPO at top of range, sources sayBirkenstock Holding Ltd (BIRK.N) has secured enough commitments from investors to price its U.S. initial public offering (IPO) at the top of its indicated range and attain a $10 billion valuation, according to people familiar with the matter.
Lire la suite »
Birkenstock eyes pricing IPO at top of range -sourcesBirkenstock eyes pricing IPO at top of range -sources
Lire la suite »
Jim Cramer's top 10 things to watch in the stock market MondayThe Dow, S&P 500 and Nasdaq were lower Monday after Hamas conducted a surprise attack on Israel.
Lire la suite »
Jim Cramer explains why the Israel-Hamas war may not steer Monday's market actionCNBC’s Jim Cramer suggested the deadly conflict between Israel and Hamas may not be the driving force in Monday’s market action.
Lire la suite »